Stockreport

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from ear [Read more]